文献速递瓣膜外科

二尖瓣术后永久起搏器植入的风险因素与长期结局

Permanent pacemaker implantation following mitral valve surgery: a retrospective cohort study of risk factors and long-term outcomes.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

该回顾性队列研究纳入2011至2019年接受二尖瓣手术的成年患者3391例,排除术前已植入永久起搏器者,分析术后永久起搏器植入的风险因素及与长期生存的关系。多因素分析显示年龄增加、合并主动脉瓣或三尖瓣手术及既往心肌梗死是预测因素,孤立二尖瓣修复中使用成形环也与起搏器植入相关。术后起搏器植入与较差长期生存相关,但并非独立预测因素。

要点

  • 年龄每增加10年、合并主动脉瓣或三尖瓣手术、既往心梗增加术后起搏器风险。
  • 孤立二尖瓣修复中,使用成形环比成形带起搏器风险更高。
  • 术后起搏器植入与较差长期生存相关,但非独立预测因素。

核心结论

  • 年龄增加、合并主动脉瓣或三尖瓣手术及既往心肌梗死是二尖瓣术后永久起搏器植入的风险因素。
  • 在孤立二尖瓣修复中,使用成形环与起搏器植入风险相关。
  • 术后起搏器植入与较差长期生存相关,但并非独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2011至2019年接受二尖瓣手术的成年患者3391例(非起搏器组2991例,起搏器组400例)。

主要发现

  • 年龄每增加10年,起搏器植入风险比值比为1.23(95%CI 1.12-1.35)。
  • 合并主动脉瓣手术比值比为1.44(95%CI 1.10-1.90),合并三尖瓣手术比值比为2.21(95%CI 1.64-2.97)。
  • 既往心肌梗死比值比为1.48(95%CI 1.07-1.86)。
  • 孤立二尖瓣修复中使用成形环比值比为3.09(95%CI 1.19-8.02)。
  • 置换组患者未发现显著可识别的风险因素。

临床怎么用

  • 对高龄、合并主动脉瓣或三尖瓣手术、既往心梗的二尖瓣手术患者应警惕术后起搏器植入风险。
  • 在孤立二尖瓣修复中,选择成形环或成形带时需权衡起搏器植入风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Conduction disturbances requiring permanent pacemaker (PPM) implantation remain a complication following valvular surgery. PPMs confer the risk of infection, tricuspid valve regurgitation and pacing-induced cardiomyopathy. Literature examining PPM placement in mitral valve surgery (MVS) is limited. METHODS: Our institutional mitral valve (MV) database was retrospectively reviewed for adult patients undergoing surgery from 2011 to 2019. Patients with preoperative PPM were excluded. Patients were stratified by the receipt of PPM following their index operations. Multivariable logistic regression was performed to determine patient and operative risk factors for PPM. Subgroup analysis was performed on patients who underwent isolated MVS. Kaplan-Meier analysis and a multivariable Cox proportional hazards model were utilized to assess the association between PPM implantation and long-term survival. RESULTS: A total of 3391 (2991 non-PPM and 400 PPM) patients met the study criteria. Significant predictors of PPM included increased decade of age (odds ratio: 1.23; 95% confidence interval: 1.12-1.35), concomitant aortic (1.44; 1.10-1.90) and tricuspid valve procedures (2.21; 1.64-2.97) and prior history of myocardial infarction (1.48; 1.07-1.86). In the isolated MV repair population, annuloplasty with ring prosthesis was associated with PPM (3.09; 1.19-8.02). Patients in the replacement population did not have significant identifiable risk factors. There was no survival difference found, and postoperative PPM placement was not found to be an independent predictor of mortality. CONCLUSIONS: Our primary aim was to elucidate predictors for PPM implantation in MVS and found increasing age and concomitant procedures to be risk factors. Receipt of PPM is associated with worse long-term survival but does not independently predict survival. Among patients undergoing isolated MV repair, use of an annuloplasty ring confers a higher risk of PPM compared to an annuloplasty band.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Helmers MR, Shin M, Iyengar A, et al. Permanent pacemaker implantation following mitral valve surgery: a retrospective cohort study of risk factors and long-term outcomes. Eur J Cardiothorac Surg. 2021. PMID: 33659995. doi:10.1093/ejcts/ezab091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。